A clinical trial by Mayo Clinic found a lower dose of steroids to be as effective as the standard high-dose treatment in improving overall survival rates for multiple myeloma patients. The new regimen, lenalidomide plus low-dose dexamethasone, showed significantly better results with less toxicity.
A recent study by Mayo Clinic found that relatives of patients with Parkinson's disease are at increased risk for developing depression and anxiety disorders. The risk is particularly elevated in families where the patient develops Parkinson's before age 75.
Researchers at Mayo Clinic have developed a new imaging technology called magnetic resonance elastography (MRE) that can provide images of affected muscles with greater clarity than traditional MRI. This technology measures tissue elasticity and can detect abnormal hardening of tissues, which is a hallmark of myofascial pain syndrome.
A Mayo Clinic study shows cryoablation can provide durable pain relief for patients with bone metastases. Eighty percent of patients experienced significant pain reduction after the treatment, which also improved their quality of life.
A review of 62 Mayo Clinic patients who underwent cryoablation to treat cancerous kidney tumors found that all patients remained cancer-free for up to two and a half years after the procedure. The treatment's effectiveness was demonstrated by the successful elimination of 89 out of 91 tumors in a single treatment session.
Researchers evaluated mycophenolate mofetil to reduce lupus flares in SLE patients and found significant reductions, especially for severe flares. The treatment was effective even with reduced use of anti-inflammatory drug prednisone.
Researchers at Mayo Clinic developed a simple approach to predict heart disease in rheumatoid arthritis patients, finding 85% of those 60-69 year olds had a 1 in 5 chance of developing serious cardiovascular events. The study emphasizes the importance of comprehensive cardiovascular risk assessment for all newly diagnosed patients.
Mayo Clinic researchers will study renal vascular disease caused by atherosclerosis to find new ways to diagnose and treat the condition. The study aims to develop novel imaging tools to predict, detect, and evaluate the disease, with the goal of preventing renal deterioration.
A Mayo Clinic study reveals that over half of heart attack patients discontinue taking prescribed medications within three years. Smokers are more likely to stop taking all their medications in the short term, while those in cardiac rehabilitation programs tend to continue medication at a higher rate than non-participants.
The study found that patients who arrived at the hospital within one to two hours of onset had a 77% higher rate of receiving reperfusion therapy, compared to those who waited 11-12 hours. Delayed arrival resulted in lower rates of reperfusion therapy and poorer treatment outcomes.
Researchers at Mayo Clinic found no link between diabetes treatment and survival rates after a heart attack. The study, which analyzed data from over 2,700 patients, suggests that commonly used medications for managing blood sugar levels do not reduce the likelihood of survival after a heart attack.
A Mayo Clinic study found that modest weight gain in lean, healthy young adults impairs blood vessel function, but shedding the weight restores proper functioning. Visceral fat is a key predictor of this disorder, also known as endothelial dysfunction, which can lead to heart attacks and strokes.
Three anesthesiologists and a medical ethicist discuss whether doctors should participate in state-ordered executions, citing technical problems with lethal injection. They argue that doctors can minimize suffering, but others propose replacing anesthesia-related drugs with alternative personnel.
Mayo Clinic researchers found that 2ME2 can effectively target breast cancer cells, prevent the spread of breast cancer to bone and protect bone from osteolysis. The study's findings suggest that 2ME2 could be a new therapy in treating advanced breast cancer.
A new study by Mayo Clinic researchers found that massage therapy decreases pain levels for patients after heart surgery. In a pilot study of 58 patients, those who received massage had mean pain scores less than 1 on a scale of 1 to 10, compared to an average rating of 3 among the control group.
Researchers at Mayo Clinic Jacksonville found that partial breast irradiation can expose as much lung and heart tissue to potentially toxic radiation as whole breast irradiation. This suggests that both methods carry equivalent risks and benefits.
Researchers at Mayo Clinic Jacksonville have found that tiny radioactive spheres can effectively treat cancer that has spread to the liver, halting tumor growth in 71% of patients. The treatment works by delivering radiation directly to tumors using millions of tiny polymer beads containing yttrium-90.
Researchers found that younger patients with colon cancer have shorter telomeres than expected, suggesting a possible biomarker for early detection. The study also found gender differences in the incidence of colon cancer among young people.
A new Mayo Clinic study presents a chromosome test called 'FISH' as a better method for identifying genetic abnormalities in patients with plasma cell malignancies. This improved analysis may help physicians assess patient prognosis and treatment response more accurately.
A Phase II trial of a new combination therapy for patients with platinum-resistant ovarian cancer showed a 33% overall response rate, twice as high as traditional chemotherapy regimens. The therapy combines flavopiridol and cisplatin and is promising for developing more effective treatments for this disease.
Research suggests viruses like Human Ad-36 may play a role in causing obesity in humans, with evidence showing weight gain and fat storage in infected animals. Studies also found connections between viral infections and obesity in human subjects, including exposure to the Ad-36 virus.
Primary central nervous system vasculitis is a rare and poorly understood disorder that can lead to stroke or death. A recent Mayo Clinic study provides clarification on the methods of diagnosis and treatment, suggesting a combined diagnostic approach using angiography, brain biopsy, and laboratory studies.
Researchers at Mayo Clinic have discovered an antibody that can repair the damaged myelin sheath in laboratory mouse models, a crucial step towards treating multiple sclerosis and related disorders. The antibody promotes remyelination with a single dose, paving the way for potential new treatments.
A literature review published in Mayo Clinic Proceedings finds that many patients with chronic heart failure can engage in sexual activity with proper screening and treatment. The authors analyzed studies on the impact of sexual activity on heart rate and blood pressure, showing moderate oxygen consumption levels comparable to normal d...
A Mayo Clinic review of patients' responses to droperidol found no proven cases of complications directly attributable to the drug's use. The study suggests that alternative medications may not be as effective in controlling nausea and vomiting, leading some anesthesiologists to resume low-dose use of droperidol.
Most diabetes drug trials prioritize reducing blood sugar levels over patient-relevant outcomes like complication risk and quality of life. This can lead to ineffective treatments that cause more harm than good.
Researchers at Mayo Clinic discovered that loss of progranulin gene causes errant splicing of a protein that disrupts normal functioning of neurons. Accumulation of toxic TDP-43 proteins is found in several neurodegenerative diseases, including Alzheimer's Disease and Frontotemporal Dementia.
A recent study suggests that an abnormal amount of inflammatory cells in the duodenum may be responsible for nonulcer dyspepsia, a condition characterized by chronic or recurrent abdominal pain. The researchers propose targeted anti-inflammatory medicine as a potential treatment option.
A Mayo Clinic study of nearly 5,000 children with ADHD found that treatment with prescription stimulants was associated with improved long-term academic success. The study also showed that girls with untreated ADHD were equally vulnerable to poor school outcomes as boys and may be at risk for being undertreated.
Researchers discovered that first-degree relatives of PBC patients have a higher prevalence of anti-mitochondrial antibodies, a biomarker indicative of the disease. This finding enables early screening and assessment of high-risk family members through simple blood tests, potentially leading to better outcomes for PBC patients.
A new Mayo Clinic study published in Value in Health found no significant difference between abciximab and eptifibatide in hospital stay length or cardiovascular event rates. The study provides data to guide treatment decisions for heart patients undergoing angioplasty.
Anesthesiologists and medical ethicist discuss pros and cons of doctors participating in state-ordered executions. Some argue that humane methods can be used to minimize suffering, while others believe it violates the Hippocratic oath and compromises medical professionalism.
A pilot study by Mayo Clinic researchers found that flaxseed therapy decreased hot flashes in postmenopausal women by 50% and improved their quality of life. The study also showed improvements in mood, joint pain, and overall health.
The study found that women who had both ovaries removed but were treated with estrogen until age 50 did not have an increased risk of cognitive impairment or dementia. Women who had one or both ovaries removed before menopause faced a higher long-term risk of cognitive impairment or dementia compared to those who retained their ovaries.
Mayo Clinic researchers have discovered a new diagnostic test to detect infection in prosthetic joints, which samples bacteria adhering to the prosthesis surface. The new method detected more infected cases (78.5%) than conventional tests (60.8%), offering improved treatment options and patient outcomes.
Researchers discovered B7-H3, an immune molecule that predicts prostate cancer progression and recurrence after surgery. The biomarker can help individualize treatment plans for patients.
Reactivating a key gene, sFRP-1, has been shown to stop tumor growth and reduce metastasis in clear cell renal cell carcinoma. The study found that sFRP-1 controlled 13 tumor-promoting genes along the Wnt signaling pathway, which is linked to various cancers.
A recent study published in Mayo Clinic Proceedings found that patients prescribed cholesterol-lowering medications do not necessarily adopt unhealthy diets. Despite taking statins, patients made good faith efforts to improve their health through lifestyle changes.
A preliminary study of 85 patients with bipolar disorder shows that modafinil can improve depressive symptoms, with 44% of participants reporting improved symptoms and 39% experiencing remission after six weeks.
Mayo Clinic physicians found that obese patients who received an obesity diagnosis were more likely to form a weight loss management plan than those without a diagnosis. The study highlights the importance of proactive discussion between physicians and patients about obesity, a risk factor for diabetes and cardiovascular diseases.
A Mayo Clinic-led collaborative study finds that focused ultrasound treatment of uterine fibroids offers sustained symptom relief and durable outcomes. The more complete destruction of tumors by focused ultrasound results in improved quality of life and lower incidence of severe side effects.
A new therapy, certolizumab pegol, has been found to be effective in easing symptoms of patients with active Crohn's disease. The treatment was shown to improve clinical symptoms in both short-term and long-term maintenance therapies, offering a potential new option for managing the condition.
Mayo Clinic physicians have developed a new technique using real-time 3-D ultrasound to block nerve function in selected areas of the body prior to surgery. This allows patients to recover faster and with less need for pain medication. The technique has been successfully used in over 150 surgeries, showing improved outcomes for patients.
A study by Shinshu University Graduate School of Medicine found that high-intensity interval walking may protect against high blood pressure and decreased muscle strength in older adults. Walking is a legitimate mode of exercise that doesn't require special equipment or membership, according to Dr. James Levine.
A recent study published in the Journal of Clinical Oncology found that women with atypia in their breast tissue are nearly eight times more likely to develop breast cancer. The study, led by Mayo Clinic, improved risk prediction by taking into account age at diagnosis and multiple sites of atypical hyperplasia.
Researchers found that mice without CD38 were protected from high-fat diet-induced obesity and glucose intolerance. The study suggests that a CD38 deficiency has a protective effect against obesity, highlighting the importance of genes in regulating body weight.
A new study from Mayo Clinic researchers reveals that the joint effects of common DNA variations in several genes within a well-defined biological pathway largely explain why some people develop Parkinson’s disease. The findings also predict with great accuracy at what age people might develop their first symptoms.
Four-year data from two large clinical trials found that trastuzumab significantly improves disease-free survival and overall survival rates in women with HER2-positive breast cancer. The study showed a 52% decrease in the risk of disease recurrence and a 35% reduction in mortality rates compared to chemotherapy alone.
Researchers found vorinostat's anti-cancer activity in patients with recurrent glioblastoma multiforme, with a 15% patient success rate and improved median overall survival. The study aimed to explore the novel application of vorinostat in targeting brain cancer.
A Phase II study has shown that combining chemotherapy drugs with an antiangiogenic agent can significantly delay the spread of tumors in patients with metastatic melanoma. The treatment, which included paclitaxel and carboplatin with bevacizumab, prevented tumor growth for almost six months and improved survival rates.